Seyed Ahmad Rasoulinejad (Amirhosein Maali)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Epigenomics

Molecular biotechnology

Journal of immunoassay & immunochemistry

Cellular reprogramming

Pasteur Institute of Iran (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Pasteur Institute of Iran

Iran

PHD

Publications

Tahereh Hojjatipour, Seyed Ahmad Rasoulinejad, Mehdi Azad
Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy. Epigenomics (2023)
Tahereh Hojjatipour, Seyed Ahmad Rasoulinejad, Mehdi Azad
Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy. Epigenomics 15 (4) (2023)
Tahereh Hojjatipour, Seyed Ahmad Rasoulinejad, Mehdi Azad
Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy. Epigenomics 15 (4) (2023)
Mohammad Reza Lahimchi, Faezeh Maroufi, Seyed Ahmad Rasoulinejad
Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy. Cellular reprogramming (2023)
Mahin Lashgari, Sanaz Keshavarz Shahbaz, Amir Javadi, Mehdi Sahmani, Maryam Khalaji, Seyed Ahmad Rasoulinejad, Farshad Foroughi
Survey of the association between polymorphisms of CTLA-4 exon 1 49 A/G genes with rheumatoid arthritis in Iran. Journal of immunoassay & immunochemistry 43 (5) (2022)
Seyed Ahmad Rasoulinejad, Faezeh Maroufi
CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases. Molecular biotechnology 63 (9) (2021)
Seyed Ahmad Rasoulinejad, Faezeh Maroufi, Farzin Sadeghi, Amir Atashi, Reza Kouchaki, Mona Moghadami, Mehdi Azad
Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics. Epigenomics 13 (8) (2021)
Faezeh Maroufi, Seyed Ahmad Rasoulinejad, Meghdad Abdollahpour-Alitappeh, Mohammad Hossein Ahmadi, Mehdi Azad
CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy. Epigenomics 12 (20) (2020)

Seyed Ahmad Rasoulinejad.css-eqlu8i{font-size:small;padding-left:4px;} (Amirhosein Maali)

Publication Activity (10 Years)

Top Topics

Top Venues

Seyed Ahmad Rasoulinejad (Amirhosein Maali)